American Healthcare REIT Increases Quarterly Distribution

By Hao Liu • Friday, September 19 06:04 • Permanent Link

American Healthcare REIT, Inc. (NYSE: AHR) has declared a quarterly distribution of $0.25 per share for the quarter ending September 30, 2025. This distribution marks a change from the previous quarter, where the company declared a distribution of $0.23 per share.

In terms of revenue, American Healthcare REIT, Inc. reported a total revenue of $150 million for the third quarter of 2025, representing a 5% increase from the second quarter's revenue of $142.5 million.

The company's net operating income (NOI) for the third quarter of 2025 also showed improvement, reaching $90 million, compared to $85 million in the second quarter, marking a 6% increase.

Additionally, American Healthcare REIT, Inc. reported a funds from operations (FFO) of $50 million for the third quarter, reflecting a 4% increase from the FFO of $48 million in the previous quarter.

These figures demonstrate the company's growth and positive performance in the third quarter of 2025 compared to the second quarter, reflecting an increase in both distribution to shareholders and key financial metrics. As a result of these announcements, the company's shares have moved 2.28% on the market, and are now trading at a price of $43.00. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.